Advertisement
Advertisement
XTNT
Xtant Medical Holdings, Inc.
0.29
USDSponsored
-0.01
-4.00%
Nov 06, 11:33 UTC -5
Open
Xtant Medical Holdings, Inc. (XTNT) Earnings
XTNT Earnings Reports
Positive Surprise Ratio
XTNT beat 14 of 31 last estimates.
45%
Next Report
Today
Date of Next Report
Nov 06, 2026
Estimate for Q3 26 (Revenue/ EPS)
$26.02M
/-$0.02
Implied change from Q2 26 (Revenue/ EPS)
+12.99%
/-33.33%
Implied change from Q3 25 (Revenue/ EPS)
-21.75%
/-300.00%
Xtant Medical Holdings, Inc. earnings per share and revenue
On Aug 11, 2026, XTNT reported earnings of -0.03 USD per share (EPS) for Q2 26, missing the estimate of -0.02 USD, resulting in a -47.06% surprise. Revenue reached 23.03 million, compared to an expected 25.37 million, with a -9.23% difference. The market reacted with a -28.25% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 26.02 million USD, implying an decrease of -33.33% EPS, and increase of 12.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
FAQ
What were Xtant Medical Holdings, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Xtant Medical Holdings, Inc. reported EPS of -$0.03, missing estimates by -47.06%, and revenue of $23.03M, -9.23% below expectations.
How did the market react to Xtant Medical Holdings, Inc.'s Q2 2026 earnings?
The stock price moved down -28.25%, changed from $0.45 before the earnings release to $0.32 the day after.
When is Xtant Medical Holdings, Inc. expected to report next?
The next earning report is scheduled for Nov 06, 2026.
What are the forecasts for Xtant Medical Holdings, Inc.'s next earnings report?
Based on 4
analysts, Xtant Medical Holdings, Inc. is expected to report EPS of -$0.02 and revenue of $26.02M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.